Silvio E. Inzucchi
Diabetes Care · 2000–2022
A researcher in the Science corpus: 23 papers; trusts 0 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Whom Silvio E. Inzucchi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Silvio E. Inzucchi overall
- R. B. Haynes
- Massimo F. Piepoli
- H. Mcdonald
- V. Basevi
- John B. Buse
- E. Ferrannini
- D. Nathan
- Amit X. Garg
- C. Bailey
- Nur Samsu
Papers from Silvio E. Inzucchi's perspective
Ordered by how strongly the researchers Silvio E. Inzucchi trusts endorse each paper. Same corpus, a different order for every researcher.
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. (The Lancet)
- Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials (Journal of the American Medical Association (JAMA))
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study (British medical journal)
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
- Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (Diabetes Care)
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
- Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity (Annals medicus)
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)
Their papers
- The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. (2002) — 648 citations
- Mechanism by which metformin reduces glucose production in type 2 diabetes. (2000) — 1,065 citations
- Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. (2002) — 708 citations
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2014) — 2,951 citations
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control (2009) — 1,619 citations
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. (2022) — 1,690 citations
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. (2020) — 853 citations
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. (2019) — 5,091 citations
- How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial (2017) — 631 citations
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. (2016) — 3,043 citations
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial (2016) — 905 citations
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. (2015) — 5,975 citations
- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2015) — 732 citations
- Metformin in patients with type 2 diabetes and kidney disease: a systematic review. (2014) — 609 citations
- Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2013) — 2,521 citations
- Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 (2013) — 1,101 citations
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) — 3,782 citations
- How Do We Define Cure of Diabetes? (2009) — 983 citations
- Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. (2009) — 850 citations
- Standards of Medical Care in Diabetes—2008 (2008) — 1,077 citations